{"result": {"id": "a07129a9-03de-41f7-ba4b-d5be80fee0aa", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>NON-SEVERE HYPERTENSION<|>EVENT<|>Non-severe hypertension in pregnant women requires initiating antihypertensive treatment and adjusting medication based on blood pressure levels during pregnancy. Monitoring blood pressure, urine protein, and fetal condition is essential.\")\n##\n(\"entity\"<|>SEVERE HYPERTENSION<|>EVENT<|>Severe hypertension in pregnant women requires urgent treatment to minimize maternal and perinatal complications. Management includes determining the duration of treatment, target blood pressure, drug selection, and indications for terminating pregnancy.\")\n##\n(\"entity\"<|>PREECLAMPSIA<|>EVENT<|>A condition in pregnant women characterized by severe hypertension and proteinuria, requiring intravenous magnesium sulfate as first-line treatment to prevent or treat eclampsia.\")\n##\n(\"entity\"<|>ECLAMPSIA<|>EVENT<|>A severe complication of preeclampsia involving seizures, requiring immediate medical intervention.\")\n##\n(\"entity\"<|>HYPERTENSIVE EMERGENCY<|>EVENT<|>A critical condition in pregnant women with systolic blood pressure ≥180mmHg or diastolic blood pressure ≥120mmHg, requiring urgent treatment measures.\")\n##\n(\"entity\"<|>LABETALOL<|>ORGANIZATION<|>An alpha and beta-blocker used as an oral and intravenous antihypertensive drug during pregnancy, with potential side effects like fetal bradycardia and skin itching.\")\n##\n(\"entity\"<|>NIFEDIPINE<|>ORGANIZATION<|>A calcium channel blocker used to treat hypertension in pregnancy, available in immediate-release, sustained-release, and controlled-release formulations.\")\n##\n(\"entity\"<|>METHYLDOPA<|>ORGANIZATION<|>An antihypertensive drug that reduces sympathetic nervous system activity, used during pregnancy with potential side effects like depression and hypotension.\")\n##\n(\"entity\"<|>POSTPARTUM HYPERTENSION<|>EVENT<|>Hypertension occurring in more than 50% of HDP patients within 72 hours postpartum, requiring close monitoring and continued antihypertensive treatment.\")\n##\n(\"relationship\"<|>NON-SEVERE HYPERTENSION<|>SEVERE HYPERTENSION<|>Both are conditions of hypertension in pregnant women but differ in severity and treatment approach<|>6)\n##\n(\"relationship\"<|>PREECLAMPSIA<|>ECLAMPSIA<|>Eclampsia is a severe progression of preeclampsia involving seizures<|>8)\n##\n(\"relationship\"<|>SEVERE HYPERTENSION<|>HYPERTENSIVE EMERGENCY<|>Severe hypertension can escalate into a hypertensive emergency if not treated promptly<|>7)\n##\n(\"relationship\"<|>LABETALOL<|>NIFEDIPINE<|>Both are commonly used antihypertensive drugs for treating hypertension in pregnancy<|>5)\n##\n(\"relationship\"<|>METHYLDOPA<|>LABETALOL<|>Both are antihypertensive medications recommended for use during pregnancy<|>5)\n##\n(\"relationship\"<|>POSTPARTUM HYPERTENSION<|>HDP<|>Postpartum hypertension is a common complication in women with hypertensive disorders of pregnancy (HDP)<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558711, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 712, "prompt_tokens": 2435, "total_tokens": 3147, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 643}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 非重度和重度高血压孕妇应采取不同的降压治疗 策略。\n　　　(1)非重度高血压 :应启动降压治疗 ,根据妊娠期 间血压水平变化及时调整药物治疗方案 ,原则上如中 低剂量的单药治疗不能达标时 ,应联合另外一种中低 剂量药物治疗 , 而非增加单药剂量[514] 。需监测孕妇 血压水平及尿蛋白变化情况及胎儿状况[515] 。\n　　　(2)重度高血压 :需要紧急处理 , 目标是最大程度 降低母儿围产期并发症发生率和死亡率 。在严密监测 母婴状态的前提下 ,应明确降压治疗的持续时间、降压 目标、药物选择和终止妊娠的指征 。若孕妇发展为重 度子痫前期或子痫 ,应静脉使用硫酸镁作为一线药物 预防/治疗子痫 。当收缩压 ≥180mmHg或舒张压 ≥ 120mmHg时 , 应按照高血压急症采取相应的处理 措施。\n　　常用的口服降压药有拉贝洛尔、硝苯地平和甲基  多巴 ,必要时可使用小剂量噻嗪类利尿剂 ,详见表 25。 常用的静脉降压药有拉贝洛尔、乌拉地尔、尼卡地平、 酚妥拉明、硝酸甘油等 ,具体参见高血压急症的处理。\n\n\n表 25   常用妊娠期高血压疾病的口服治疗药物\n\n药物名称\t降压机制\t常用剂量a\t不良反应\n拉贝洛尔\tα、β受体阻滞剂\t50~150mg,3~4次/d,最大剂量 600mg/d\t胎儿心动过缓、皮肤瘙痒\n硝苯地平\t抑制动脉平滑肌细胞钙内流\t5~20mg, 3~4次/d;或缓释制剂 10~20mg,2~3次/d;或控释制剂 30~ 60mg,1次/d\t低血压\n甲基多巴\t降低脑干交感神经张力\t200~500mg,3~4次/d\t抑郁、过度镇静、低血压\n注 :a 本指南推荐的最大剂量均低于国外推荐量[514] ,在临床实践中可依据患者的特殊情况酌情掌握。\n\n\n　7.3.6   产 后 血 压 管 理 与 远 期 心 脑 血 管 疾 病 预 防  HDP产妇中超过 50%会在产褥期出现血压 ≥150/ 100mmHg,应在分娩后 72 h 内密切监测血压 , 每天  至少监测 4~ 6 次 。产后血压 ≥140/90mmHg者应  继续降压治疗 ,根据血压恢复情况可逐渐减少药量直\n\n\n　至停药 。HDP产妇约 25%在产后 2年内都需要维持  降压治疗[516]  ,产后 10年发生高血压的风险是非 HDP 孕妇的2.4倍[517]  ,且远期心脑血管疾病的风险显著增  高[518-\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_f59808646b64bcfb42fe415c331c3112894397032e3d3f2f5f7818e46bdef484_v2"}